Cargando…

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction

Pre-existing immunity to adeno-associated virus (AAV) is highly prevalent in humans and can profoundly impact transduction efficiency. Despite the relevance to AAV-mediated gene transfer, relatively little is known about the fate of AAV vectors in the presence of neutralizing antibodies (NAbs). Simi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fitzpatrick, Zachary, Leborgne, Christian, Barbon, Elena, Masat, Elisa, Ronzitti, Giuseppe, van Wittenberghe, Laetitia, Vignaud, Alban, Collaud, Fanny, Charles, Séverine, Simon Sola, Marcelo, Jouen, Fabienne, Boyer, Olivier, Mingozzi, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948224/ https://www.ncbi.nlm.nih.gov/pubmed/29766022 http://dx.doi.org/10.1016/j.omtm.2018.02.003

Ejemplares similares

A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome
por: Ronzitti, Giuseppe, et al.
Publicado: (2016)

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
por: Meliani, Amine, et al.
Publicado: (2018)

Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics
por: Barbon, Elena, et al.
Publicado: (2016)

AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice
por: Colella, Pasqualina, et al.
Publicado: (2018)

Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor
por: Barbon, Elena, et al.
Publicado: (2021)

Capsid-specific removal of circulating antibodies to adeno-associated virus vectors
por: Bertin, Berangere, et al.
Publicado: (2020)

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome
por: Collaud, Fanny, et al.
Publicado: (2018)

Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase
por: Cagin, Umut, et al.
Publicado: (2020)

Emerging Issues in AAV-Mediated In Vivo Gene Therapy
por: Colella, Pasqualina, et al.
Publicado: (2017)

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020)

Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector
por: De Sabbata, Giulia, et al.
Publicado: (2020)

Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain
por: Orefice, Nicola Salvatore, et al.
Publicado: (2019)

A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia
por: Zhukouskaya, Volha V., et al.
Publicado: (2021)

Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
por: Kanaan, Nicholas M., et al.
Publicado: (2017)

An AAV capsid increases transduction of striatum and a ChAT promoter allows selective cholinergic neuron transduction
por: Santoscoy, Miguel C., et al.
Publicado: (2023)

Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain
por: Chakrabarty, Paramita, et al.
Publicado: (2013)

AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear
por: Ivanchenko, Maryna V., et al.
Publicado: (2021)

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)

Overcoming the Challenges Imposed by Humoral Immunity to AAV Vectors to Achieve Safe and Efficient Gene Transfer in Seropositive Patients
por: Gross, David-Alexandre, et al.
Publicado: (2022)

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors
por: Barbon, Elena, et al.
Publicado: (2020)

Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly
por: Viney, Lydia, et al.
Publicado: (2021)

Peptide Ligands Incorporated into the Threefold Spike Capsid Domain to Re-Direct Gene Transduction of AAV8 and AAV9 In Vivo
por: Michelfelder, Stefan, et al.
Publicado: (2011)

Site-Directed Mutagenesis Improves the Transduction Efficiency of Capsid Library-Derived Recombinant AAV Vectors
por: Ran, Gai, et al.
Publicado: (2020)

Non-canonical amino acid incorporation into AAV5 capsid enhances lung transduction in mice
por: Chang, Hao, et al.
Publicado: (2023)

Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy
por: Armbruster, Nicole, et al.
Publicado: (2016)

Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients
por: Shi, Xiaoxia, et al.
Publicado: (2020)

Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity
por: Bartel, Melissa, et al.
Publicado: (2011)

High throughput screening of novel AAV capsids identifies variants for transduction of adult NSCs within the subventricular zone
por: Kremer, Lukas P.M., et al.
Publicado: (2021)

Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouse
por: Gilkes, Janine A., et al.
Publicado: (2020)

Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids
por: Cabanes-Creus, Marti, et al.
Publicado: (2021)

Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction
por: Han, Sang-oh, et al.
Publicado: (2017)

Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction
por: Han, Sang-oh, et al.
Publicado: (2019)

Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines
por: Ryals, Renee C., et al.
Publicado: (2011)

Engineered AAV8 capsid acquires heparin and AVB sepharose binding capacity but has altered in vivo transduction efficiency
por: van Lieshout, Laura P., et al.
Publicado: (2023)

Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects
por: Colella, Pasqualina, et al.
Publicado: (2020)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle
por: Poupiot, Jérôme, et al.
Publicado: (2019)

Tailoring the AAV2 capsid vector for bone-targeting
por: Alméciga-Díaz, Carlos J., et al.
Publicado: (2018)

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
por: Büning, Hildegard, et al.
Publicado: (2019)

Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
por: Gehrke, Miranda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i7hvihrmdf8k9e4j3pl72o7psl